Home/Pipeline/G-test Portfolio Expansion

G-test Portfolio Expansion

Gastrointestinal Diseases

DevelopmentActive

Key Facts

Indication
Gastrointestinal Diseases
Phase
Development
Status
Active
Company

About Genloxa

Genloxa is a private, revenue-generating diagnostics laboratory focused on personalized medicine in gastroenterology and oncology. Its core offerings include proprietary 'G-tests' for fecal biomarkers (calprotectin, pancreatic elastase) and the Dose5-FU test, the only service in Poland for monitoring 5-fluorouracil levels during chemotherapy to personalize dosing. The company targets both individual patients and institutional clients like hospitals, leveraging EU-funded R&D projects to expand its test menu and laboratory capabilities. Its strategy centers on providing rapid, non-invasive diagnostics to accelerate treatment decisions and improve therapeutic outcomes.

View full company profile

Therapeutic Areas

Other Gastrointestinal Diseases Drugs

DrugCompanyPhase
LAPS GLP-1/GLP-2 Dual AgonistZealand PharmaPreclinical